Latest News

A chapter on COVID-19
In one of the microbiology courses that I teach, my students will be learning about SARS-CoV-2 (the virus...
Read more
COVID-19
All of humanity is rightfully concerned about the coronavirus pandemic that is sweeping the globe. Popular...
Read more
New powerful antibiotics discovered using machine learning
Bacteria are amazing creatures. They adapt rapidly to any stress that is put on them or at least some...
Read more
Top Publishers Sued over Collusion in Textbook Market
Textbook prices are out of control and this is why I spent years of my life writing and running this...
Read more
Americans are fatter than ever and processed food is to blame
Before diving into this article we need to clarify how being obese is measured. There are many ways to...
Read more
News

News

A new antimalaria drug: less expensive, simple treatment, easy to produce

Created by paustian on May 22, 2013, 7:29 PM

 

Malaria is the most important tropical disease in the world, with over 665,000 deaths worldwide, many of them in children. The malaria parasites, protozoa of the Plasmodium genus, are susceptible to a number of drugs, but have been becoming more resistant the drugs available for treatment. Professor Jonathan Vennerstrom of the University of Nebraska Medical Center College of Pharmacy and his team announce the development of Synriam (a synthetic trioxolane) that has many of the properties of artemisinin, but none of the downsides.

The paper describing the synthesis, toxicology, and effectiveness of this trioxolane is available in Nature. I found it was interesting that this paper was published in 2004, yet the clinical trials took 8 years to complete and bring this drug to market. It demonstrates how careful governments have to be with new drugs being introduced into the market.